UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

AstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment ...

AstraZeneca scrapped a £450m vaccine plant in Liverpool after the UK government missed a critical funding deadline. The ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

UK pharma major AstraZeneca (LSE: AZN) today announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D center, as well as major research and manufacturing ...

2025年1月10日， 英国生物样本库（UK Biobank）宣布与14家生物制药巨头合作，启动了一项史上最大规模的蛋白质组学研究项目 ...

AstraZeneca shares have recovered from their brief slump with investors broadly buoyed by the company’s long-term business ...

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...

Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, ...

AstraZeneca has struck a deal to acquire biotechnology company EsoBiotec for up to $1bn, as the London-listed pharmaceutical ...